Stock Pick

Morgans just bumped up its price target for this booming ASX financials stock

Written by

openjargon

in

A man leaps from a stack of gold coins to the next, each one higher than the last.

Solvar Ltd (ASX: SVR) has been an outstanding ASX financials stock to own over the last year. 

It is a financial services company specialising in providing finance and other related services to assist consumers with the purchase of a new or used vehicle, as well as offering personal loans to consumers.

12 months ago Solvar shares were trading for roughly $1.38. 

Yesterday, this ASX financials stock closed at $1.86. 

That’s a rise of 34%.

For context, the S&P/ASX 200 Index (ASX: XJO) is up roughly 7.9% in that same span. 

On Wednesday, the company released H1 FY26 results.

Let’s see what the company reported. 

Earnings growth 

In Wednesday’s announcement, for the half year ended 31 December 2025 (H1 FY26), the company reported: 

  • Normalised Net Profit After Tax (NPAT) of $20.0 million, up 5.8% on pcp;
  • Statutory NPAT of $17.8 million, up 5.8% on pcp;
  • Earnings Per Share (EPS) up 13.5% to 9.3 cents per share on pcp;
  • Fully franked interim dividend of 6.0 cents, plus a special fully franked dividend of 2.5 cents per share, totalling 8.5 cents per share payable on 7 April 2026.

Solvar also reiterated FY26 guidance of normalised NPAT of $36.0 million (including the one-off sale of the written off loan book in New Zealand).

Speaking on the outlook, Mr Scott Baldwin, CEO and Managing Director of Solvar said:

Solvar continues to invest in the development of new products and establishing a dedicated commercial lending team, with the commercial loan book now at ~$67.0 million and growing. Solvar anticipates continued growth in commercial lending as Bennji establishes itself in the market.

Investors were clearly pleased with the results as its share price is up 5.6% since the announcement. 

Morgans gives it an upgrade

Following the result, the team at Morgans increased its target price on this ASX financials stock. 

The broker said the company’s 1H26 result continued to illustrate the ongoing shift in the business as management work through the windup of New Zealand and refocus attention back towards domestic growth. 

Normalised NPAT was ahead of estimates, while net interest income was behind. 

FY26 Normalised NPAT guidance of ~$36m (i.e. NPAT of $34m plus ~$2m from one-off sale of NZ Arrears) was reiterated (implying 2H NPAT of $16m), with SVR expecting book growth momentum to improve into 2H26 lead by Bennji & AFS. Our FY26-28F Underlying NPAT forecasts lift by +5%/+1%/+1%.

Following this forecast upgrade, the broker increased the price target to $2.00 (previously $1.85). 

Morgans maintained its Accumulate rating. 

Based on yesterday’s closing price of $1.86, the new price target indicates an upside of 7.53%

The post Morgans just bumped up its price target for this booming ASX financials stock appeared first on The Motley Fool Australia.

Should you invest $1,000 in Money3 right now?

Before you buy Money3 shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Money3 wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

See the 5 Stocks

* Returns as of 1 Jan 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More posts